Viewing Study NCT00004327

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-03-05 @ 6:03 PM
Study NCT ID: NCT00004327
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-10-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
Sponsor: National Center for Research Resources (NCRR)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hereditary Hemorrhagic Telangiectasia View
None Ectasia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None genetic diseases and dysmorphic syndromes View
None hematologic disorders View
None hereditary hemorrhagic telangiectasia View
None rare disease View
None senile ectasia View